Key terms
About INCR
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest INCR news
May 02
10:21am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
May 01
9:34am ET
Intercure Ltd. Files April SEC Report
Apr 04
11:06am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Apr 01
9:40am ET
Intercure Ltd. Submits SEC Compliance Report
Feb 13
4:50pm ET
InterCure provides update on Nir Oz facility in Israel
No recent press releases are available for INCR
INCR Financials
Key terms
Ad Feedback
INCR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
INCR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range